BREAKING: Cure to Coronavirus Studied on Monkeys | Buy GILD Stock?

200420 Like and subscribe. This is an archive, check the link in the end if you are owner. Could the cure double our money? Investing & Negotiating, use 32% off code ⚠️MoneyFromHome⚠️ expires 4-30-2020 https://metkevin.com/program 🦠Life: https://metkevin.com/ladder 💰Free Stocks: https://metkevin.com/webullShow more

🦠🦠Get the Life Insurance Kevin Has in 5 Minutes: https://metkevin.com/ladder 🦠🦠
📟📟3d Camera Kevin Uses (Save Sales Tax): https://metkevin.com/3dcamera
🏦M1Finance for Checking & Easy Stocks 🏦 https://metkevin.com/m1
🛍️Kevin’s Amazon Recommendations (Books, Gear, Etc.): https://metkevin.com/Gear

✅🗳️Learn from Kevin🗳️✅
🏡Real Estate Investing From $0 to Millionaire: https://metkevin.com/invest
🤵Real Estate Sales from $0 to $500k+ in Income: https://metkevin.com/Sales
💰Money, Stocks, Wealth, & Happiness: https://metkevin.com/money
🧰DIY Property Management, Rental Renovations, & Asset Protection: https://metkevin.com/DIY
🎥Livestreams: Every Morning 9am (when market is open). Join here: https://metkevin.com/live
📬 Discord📬 https://metkevin.com/discord
Coupon Code expiring 4-30-2020: MoneyFromHome.

⚠️⚠️⚠️#Cure #Coronavirus #Sub2MeetKevin⚠️⚠️⚠️

Is there a potential to double or triple your money by investing in the company that makes the potential cure & treatment for the Coronavirus and disease Covid-19? Gilead is a biopharmaceutical company that manufactures the failed-Ebola drug Remdesivir. First, it’s helpful to know there’s a difference between a cure or treatment and a vaccine. A vaccine essentially has a never-ending pool of customers. Whereas a cure’s profit is limited to people who actually get sick or fall ill with the disease. A cure, however, could be what finally let’s us open our economy, flatten the curve, and prevent future waves from putting us back into quarantine. Remdesivir has obviously gotten a lot of attention due to it’s Thursday April 16th break via anecocal evidence from the University of Chicago hospital where 113 patients were being treated with Remdesivir.

Stat, a health-news organization formed by the Boston Globe has broken a story today that Gilead's antiviral drug Remdesivir is showing significant progress in trials at the University of Chicago Hospital. This drug is in phase-3 trials and the drug has proven success in lab trials already. Human trials are now showing substantial success in human trials among severe cases of Covid-19, the disease caused by the novel Coronavirus.

On February 4th we learned that Remdesivir works well in-vitro (in test tubes).
On April 13th we learned that Remdesivir is an RNA-inhibiting anti-viral.
In March we saw doctors in Sweden trying Remdesivir on patients.
At the beginning of March multiple executives started buying Gilead stock (though some did sell some shares April).
On April 17th Reuters announced that clinical trials were being ramped up from 2,400 patients to 6,000 patients.
On April 17th the Economists found that Gilead was massively ramping up production.
—QUOTE FROM GILEAD—
Our goal is to produce a total of:
-More than 140,000 treatment courses by the end of May 2020
-More than 500,000 treatment courses by October 2020
-More than 1 million treatment courses by December 2020
-Several million treatment courses in 2021, if required
—QUOTE FROM GILEAD—

Let’s be very clear though. Harvard Professors and others are saying it’s TOO EARLY to celebrate without controlled, human studies.

Monkey study: https://metkevin.com/cure

📝Contact Kevin📝
Course Questions & Bundles ✉️ Email Kevin@MeetKevin.com
DAILY Livestreams 📺 https://metkevin.com/live
Kevin is here Regularly 📱https://metkevin.com/discord
Download Kevin’s Course 🧠 https://metkevin.com/program

➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖➖
🚧🚧🚧🚧DISCLAIMER🚧🚧🚧🚧
❎I am not a CPA, attorney, insurance, contractor, lender, or financial advisor. The content in these videos shall not be construed as tax, legal, insurance, construction, engineering, health & safety, electrical, financial advice, or other and may be outdated or inaccurate; it is your responsibility to verify all information yourself. This is a Youtube video for entertainment purposes ONLY. IF stocks or companies are mentioned, Kevin MAY have an ownership interest in them -- DO NOT make buying or selling decisions based on Kevin's videos. If you need advice, please contact a qualified CPA, attorney, insurance agent, contractor/electrician/engineer/etc. financial advisor, or the appropriate professional for the subject you would like help with. Linked items may create a financial benefit for Meet Kevin®. Any use of other media is by fair-use or license only. The Paffrath Organization is a licensed real estate brokerage doing business as Meet Kevin® in California under DRE #02032575. This is not an advertisement of property for sale. Any mention of properties listed or sale or otherwise shall not be construed as anything other than an opinion for entertainment purposes only.

Trademarked Slogans (NO use without written permission and license):
⛔️Meet Kevin ®
⛔️No-Pressure Agent ®
⛔️Providing More ®
https://rumblevideoarchive.wordpress.com/